Jie Feng
Corporate Officer/Principal bei The Hong Kong Institute of Chartered Secretaries
Aktive Positionen von Jie Feng
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
The Hong Kong Institute of Chartered Secretaries
 The Hong Kong Institute of Chartered Secretaries Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institute of Chartered Secretaries is an independent professional body that promotes the role of its members in formulating and implementing good governance policies. The private company is based in Hong Kong, Hong Kong. It also aims to develop the profession of chartered secretary and chartered governance professional in mainland China. The institute was established in 1949 as an association of members of the Chartered Governance Institute and gained local status in 1994. It has more than 6,000 members and 3,200 students. | Corporate Officer/Principal | 01.11.2018 | - |
The Chartered Governance Institute
 The Chartered Governance Institute Miscellaneous Commercial ServicesCommercial Services The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01.11.2018 | - |
TransThera Sciences (Nanjing), Inc.
 TransThera Sciences (Nanjing), Inc. BiotechnologyHealth Technology TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China. | Unternehmenssekretär | 02.08.2021 | - |
| Investor Relations Kontakt | 02.08.2021 | - |
Karriereverlauf von Jie Feng
Ehemalige bekannte Positionen von Jie Feng
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Investor Relations Kontakt | - | 30.06.2021 |
| Corporate Officer/Principal | 01.03.2014 | 01.05.2019 | |
| Unternehmenssekretär | 10.06.2020 | 30.06.2021 |
Ausbildung von Jie Feng
| School of Life Sciences | Undergraduate Degree |
| China Pharmaceutical University | Graduate Degree |
| Hong Kong Metropolitan University | Graduate Degree |
Statistik
International
| Hong Kong | 4 |
| China | 4 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Investor Relations Contact | 2 |
| Corporate Secretary | 2 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
The Hong Kong Institute of Chartered Secretaries
The Hong Kong Institute of Chartered Secretaries Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institute of Chartered Secretaries is an independent professional body that promotes the role of its members in formulating and implementing good governance policies. The private company is based in Hong Kong, Hong Kong. It also aims to develop the profession of chartered secretary and chartered governance professional in mainland China. The institute was established in 1949 as an association of members of the Chartered Governance Institute and gained local status in 1994. It has more than 6,000 members and 3,200 students. | Commercial Services |
The Chartered Governance Institute
The Chartered Governance Institute Miscellaneous Commercial ServicesCommercial Services The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom. | Commercial Services |
TransThera Sciences (Nanjing), Inc.
TransThera Sciences (Nanjing), Inc. BiotechnologyHealth Technology TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China. | Health Technology |
